Next generation of fluorine-containing pharmaceuticals, compounds currently in Phase II–III clinical trials of major pharmaceutical companies: New structural trends and therapeutic areas.
Chem. Rev. 2016, 116, 422–518. DOI: 10.1021/acs.chemrev.5b00392
研究・技術報告ページ
- ホーム
- 【総説掲載】Chem. Rev. 2016, 116, 422–518.
